Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 5
1982 3
1983 11
1984 7
1985 12
1986 12
1987 29
1988 8
1989 39
1990 17
1991 33
1992 20
1993 10
1994 29
1995 15
1996 14
1997 17
1998 13
1999 8
2000 9
2001 11
2002 7
2003 8
2004 6
2005 5
2006 6
2007 8
2008 3
2009 2
2010 4
2011 6
2012 4
2013 3
2014 5
2015 5
2016 5
2017 5
2018 7
2019 4
2020 6
2021 2
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

421 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Sucralfate versus histamine 2 receptor antagonists for stress ulcer prophylaxis in adult critically ill patients: A meta-analysis and trial sequential analysis of randomized trials.
Alquraini M, Alshamsi F, Møller MH, Belley-Cote E, Almenawer S, Jaeschke R, MacLaren R, Alhazzani W. Alquraini M, et al. J Crit Care. 2017 Aug;40:21-30. doi: 10.1016/j.jcrc.2017.03.005. Epub 2017 Mar 8. J Crit Care. 2017. PMID: 28315586 Review.
PURPOSE: To determine the impact of using sucralfate versus H2RAs for SUP on patient important outcomes. MATERIALS AND METHODS: We searched CENTRAL, MEDLINE, EMBASE, ACPJC, clinical trials registries, and conference proceedings through June 2016 for randomized controlled t …
PURPOSE: To determine the impact of using sucralfate versus H2RAs for SUP on patient important outcomes. MATERIALS AND METHODS: We se …
Sucralfate in gastritis.
Funch-Jensen P, Kristensen ES, Kruse A, Soerensen FH, Amdrup E. Funch-Jensen P, et al. Scand J Gastroenterol Suppl. 1987;127:93-6. doi: 10.3109/00365528709090958. Scand J Gastroenterol Suppl. 1987. PMID: 3475771 Clinical Trial.
A prospective randomized trial has been conducted for half a year comparing Sucralfate with a placebo in patients with symptomatological and macroscopical gastritis. Although approximately one hundred patients met the endoscopic criteria, the vast majority could not be inc …
A prospective randomized trial has been conducted for half a year comparing Sucralfate with a placebo in patients with symptomatologi …
[Sucralfate in odontostomatology. Clinical experience].
Campisi G, Spadari F, Salvato A. Campisi G, et al. Minerva Stomatol. 1997 Jun;46(6):297-305. Minerva Stomatol. 1997. PMID: 9289631 Review. Italian.
BACKGROUND: We here describe the pharmacological and pharmacodynamic characteristics of the molecule sucralfate, the aluminum subsalt of sucrose-8-sulphate, introduced in Japan in 1968 as a mucoprotector for the treatment of peptic ulcers. ...This paper describes the resul …
BACKGROUND: We here describe the pharmacological and pharmacodynamic characteristics of the molecule sucralfate, the aluminum subsalt …
Sucralfate as an Adjunct to Analgesia to Improve Oral Intake in Children With Infectious Oral Ulcers: A Randomized, Double-Blind, Placebo-Controlled Trial.
Singh NV, Gabriele GA, Wilkinson MH. Singh NV, et al. Ann Emerg Med. 2021 Sep;78(3):331-339. doi: 10.1016/j.annemergmed.2021.01.019. Epub 2021 Apr 16. Ann Emerg Med. 2021. PMID: 33867179 Clinical Trial.
METHODS: This was a randomized, double-blind, placebo-controlled trial of sucralfate versus placebo conducted between 2017 and 2018 in an urban pediatric emergency department. ...CONCLUSION: Sucralfate as an adjunct to oral analgesics was not superior to placebo in …
METHODS: This was a randomized, double-blind, placebo-controlled trial of sucralfate versus placebo conducted between 2017 and 2018 i …
Clinical studies of sucralfate in reflux esophagitis. The European experience.
Hameeteman W. Hameeteman W. J Clin Gastroenterol. 1991;13 Suppl 2:S16-20. J Clin Gastroenterol. 1991. PMID: 1885899 Review.
Sucralfate is comparable to H2-receptor antagonists in symptom improvement and healing rates. In addition, the studies reviewed have shown sucralfate to be safe and well tolerated....
Sucralfate is comparable to H2-receptor antagonists in symptom improvement and healing rates. In addition, the studies reviewed have
Topical sucralfate for prevention of peristomal wound reaction related to percutaneous endoscopic gastrostomy in children: A randomized controlled trial.
Saneian H, Mehrannia A, Sabzghabaee AM, Feizi A, Famouri F, Abtahi-Naeini B. Saneian H, et al. Dermatol Ther. 2022 Oct;35(10):e15729. doi: 10.1111/dth.15729. Epub 2022 Aug 15. Dermatol Ther. 2022. PMID: 35871473 Clinical Trial.
This clinical study aimed to evaluate the efficacy of topical sucralfate as a prophylactic intervention in the peristomal wound reaction (PWR)/infection-associated PEG insertion in children. This study was a randomized, single-blind, controlled trial recruiting child under …
This clinical study aimed to evaluate the efficacy of topical sucralfate as a prophylactic intervention in the peristomal wound react …
Sucralfate in alleviating post-tonsillectomy pain.
Freeman SB, Markwell JK. Freeman SB, et al. Laryngoscope. 1992 Nov;102(11):1242-6. doi: 10.1288/00005537-199211000-00007. Laryngoscope. 1992. PMID: 1405984 Clinical Trial.
Sucralfate significantly lowered postoperative throat pain, otalgia, and trismus. Sucralfate is a safe and well-tolerated topical agent that offers significant pain reduction and may promote healing in tonsillectomy patients....
Sucralfate significantly lowered postoperative throat pain, otalgia, and trismus. Sucralfate is a safe and well-tolerated topi
Dressings and topical agents for treating venous leg ulcers.
Norman G, Westby MJ, Rithalia AD, Stubbs N, Soares MO, Dumville JC. Norman G, et al. Cochrane Database Syst Rev. 2018 Jun 15;6(6):CD012583. doi: 10.1002/14651858.CD012583.pub2. Cochrane Database Syst Rev. 2018. PMID: 29906322 Free PMC article. Review.
The two most highly-ranked treatments both had more than 50% probability of being the best (sucralfate and silver dressings). However, the data for sucralfate was from one small study, which means that this finding should be interpreted with caution. When exploring …
The two most highly-ranked treatments both had more than 50% probability of being the best (sucralfate and silver dressings). However …
Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis.
Wang Y, Ye Z, Ge L, Siemieniuk RAC, Wang X, Wang Y, Hou L, Ma Z, Agoritsas T, Vandvik PO, Perner A, Møller MH, Guyatt GH, Liu L. Wang Y, et al. BMJ. 2020 Jan 6;368:l6744. doi: 10.1136/bmj.l6744. BMJ. 2020. PMID: 31907166 Free PMC article.
OBJECTIVE: To determine, in critically ill patients, the relative impact of proton pump inhibitors (PPIs), histamine-2 receptor antagonists (H2RAs), sucralfate, or no gastrointestinal bleeding prophylaxis (or stress ulcer prophylaxis) on outcomes important to patients. ... …
OBJECTIVE: To determine, in critically ill patients, the relative impact of proton pump inhibitors (PPIs), histamine-2 receptor antagonists …
Sucralfate therapy in NSAID bleeding gastropathy.
Malagelada JR, Rodríguez de la Serna A, Dammann HG, Pons M, Armas C, Sala M, Tena X, Celdrán E, Mesa A. Malagelada JR, et al. Clin Gastroenterol Hepatol. 2003 Jan;1(1):51-6. doi: 10.1053/jcgh.2003.50008. Clin Gastroenterol Hepatol. 2003. PMID: 15017517 Clinical Trial.
RESULTS: Twenty-five patients received sucralfate and 25 received placebo. At the end of the study, 68% (17/25) of patients given sucralfate had no lesions (Lanza grade 0) on endoscopy compared with 35% (8/23) in controls (P = 0.042). The Lanza grades in patients gi …
RESULTS: Twenty-five patients received sucralfate and 25 received placebo. At the end of the study, 68% (17/25) of patients given …
421 results